Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 18
1979 35
1980 29
1981 25
1982 23
1983 34
1984 30
1985 33
1986 50
1987 42
1988 38
1989 41
1990 58
1991 46
1992 63
1993 68
1994 85
1995 69
1996 82
1997 74
1998 76
1999 60
2000 59
2001 52
2002 44
2003 53
2004 42
2005 46
2006 56
2007 53
2008 31
2009 32
2010 28
2011 26
2012 25
2013 22
2014 15
2015 19
2016 22
2017 22
2018 21
2019 20
2020 12
2021 5
2022 13
2023 15
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

1,749 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacology of selegiline.
Gerlach M, Youdim MB, Riederer P. Gerlach M, et al. Neurology. 1996 Dec;47(6 Suppl 3):S137-45. doi: 10.1212/wnl.47.6_suppl_3.137s. Neurology. 1996. PMID: 8959982 Review.
Metabolism of selegiline [(-)-deprenyl)].
Kalász H, Magyar K, Szőke É, Adeghate E, Adem A, Hasan MY, Nurulain SM, Tekes K. Kalász H, et al. Curr Med Chem. 2014;21(13):1522-30. doi: 10.2174/0929867321666131218094352. Curr Med Chem. 2014. PMID: 24350849 Review.
Selegiline: a molecule with innovative potential.
Tábi T, Vécsei L, Youdim MB, Riederer P, Szökő É. Tábi T, et al. J Neural Transm (Vienna). 2020 May;127(5):831-842. doi: 10.1007/s00702-019-02082-0. Epub 2019 Sep 27. J Neural Transm (Vienna). 2020. PMID: 31562557 Free PMC article. Review.
Selegiline-transdermal--Somerset: Emsam.
[No authors listed] [No authors listed] Drugs R D. 2003;4(1):59-60. doi: 10.2165/00126839-200304010-00012. Drugs R D. 2003. PMID: 12568641 Review. No abstract available.
Efficacy and safety of selegiline across different psychiatric disorders: A systematic review and meta-analysis of oral and transdermal formulations.
Rossano F, Caiazza C, Sobrino A, Solini N, Vellucci A, Zotti N, Fornaro M, Gillman K, Cattaneo CI, Van den Eynde V, Birkenhager TK, Ruhé HG, Stahl S, Iasevoli F, de Bartolomeis A. Rossano F, et al. Eur Neuropsychopharmacol. 2023 Jul;72:60-78. doi: 10.1016/j.euroneuro.2023.03.012. Epub 2023 Apr 21. Eur Neuropsychopharmacol. 2023. PMID: 37087864
Transdermal selegiline.
Patkar AA, Pae CU, Zarzar M. Patkar AA, et al. Drugs Today (Barc). 2007 Jun;43(6):361-77. doi: 10.1358/dot.2006.43.6.1050794. Drugs Today (Barc). 2007. PMID: 17612708 Review.
MPTP parkinsonism.
Williams A. Williams A. Br Med J (Clin Res Ed). 1984 Nov 24;289(6456):1401-2. doi: 10.1136/bmj.289.6456.1401. Br Med J (Clin Res Ed). 1984. PMID: 6437573 Free PMC article. No abstract available.
1,749 results